Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane(®)) on three treatment schedules in patients with solid tumors

PURPOSE: Albumin-bound paclitaxel, ABI-007 (Abraxane (®)), has a different toxicity profile than solvent-based paclitaxel, including a lower rate of severe neutropenia. The combination of ABI-007 and carboplatin may have significant activity in a variety of tumor types including non-small and small...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stinchcombe, Thomas E., Socinski, Mark A., Walko, Christine M., O’Neil, Bert H., Collichio, Frances A., Ivanova, Anastasia, Mu, Hua, Hawkins, Michael J., Goldberg, Richard M., Lindley, Celeste, Dees, E Claire
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860386/
https://ncbi.nlm.nih.gov/pubmed/17285317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-007-0423-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados